Ciprofol for general anesthesia via laryngeal mask in day surgery: a randomized, control, clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200065474

Enrollment

Unknown

Registered

2022-11-05

Start date

2022-12-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecology disease

Interventions

Propofol Group (Group B):Anesthesia induction with propofol

Ciprofol Group (Group H):Anesthesia induction with ciprofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65 years had ASA grade I-II; 2. In day surgery.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular or pulmonary disease; 2. Hepatic and renal insufficiency; 3. Abnormal blood coagulation; 4. Nervous system diseases; 5. History of chronic pain.

Design outcomes

Primary

Measure	Time frame
Injection pain;Time taken for modified obsevers assessment of alertness/sedation scale (MOAA/S) <= 1;Time taken by bispectral index (BIS) <= 60;Disappearance time of eyelash reflex;heart rate;Blood pressure;BIS;SpO2;	—

Secondary

Measure	Time frame
Respiratory inhibition;Dizzy;numerical rating scale (NRS) score;Ramsay score;	—

Countries

China

Contacts

Public ContactYuan Zhao

Hu'nan Provincial People's Hospital

no861@163.com+86 13755106141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026